Published in Cancer Weekly, December 24th, 2002
As a result of this outcome, LICR plans to extend the studies to include additional samples from LICR branches around the world. The information generated in this and future projects will be compatible with the data generated under Lynx's existing service agreement with the National Cancer Institute (NCI). In fact, as with DNA-sequence databases, all MPSS data can be combined and compared with those from other investigators worldwide.
"We are delighted with the results from the initial...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.